ReviewCurrent diabetes reports2019
Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.
Review in Current diabetes reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Mailed Letter Versus Phone Call to Increase Diabetic-Related Retinopathy Screening Engagement by Patients in a Team-Based Primary Care Practice: Prospective, Single-Masked, Randomized Trial.Journal of medical Internet research · 2023Trial
- Exploring the Role of Portable Ophthalmic Devices in Clinical and Nonclinical Settings: Qualitative Study of Ophthalmologists and Optometrists.JMIR medical informatics · 2026Article
- Barriers and facilitators to the use of tele-ophthalmology in diabetic eye care: a scoping review.BMC health services research · 2026Article
- Performance of a Retinal Imaging Camera With On-Device Intelligence for Primary Care: Retrospective Study.JMIR formative research · 2025Article
- Article
- Teleophthalmology provides earlier eye care access for patients with newly-diagnosed diabetes.Heliyon · 2024Article
- Article
- Effect of Accessible Nonmydriatic Retinal Imaging on Diabetic Retinopathy Surveillance Rates.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023Article
- Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity.Current diabetes reports · 2023Review
- Examining the Role of Telemedicine in Diabetic Retinopathy.Journal of clinical medicine · 2023Review
- Planning an artificial intelligence diabetic retinopathy screening program: a human-centered design approach.Frontiers in medicine · 2023Article
- Ultra-Widefield Imaging as a Teleophthalmology Screening Tool for Ocular Pathology.Clinical ophthalmology (Auckland, N.Z.) · 2023Article
- Protocol for a systematic review and meta-analysis of the diagnostic accuracy of artificial intelligence for grading of ophthalmology imaging modalities.Diagnostic and prognostic research · 2022Article
- Telemedicine Use by Oculoplastic Surgeons During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2022Article
- Implementation of Teleophthalmology to Improve Diabetic Retinopathy Surveillance: Qualitative Interview Study of Clinical Staff Informed by Implementation Science Frameworks.JMIR diabetes · 2022Article
- Telescreening satisfaction: disparities between individuals with diabetic retinopathy and community health center staff.BMC health services research · 2022Article
- Ophthalmology Going Greener: A Narrative Review.Ophthalmology and therapy · 2021Review
- Barriers in establishing systematic diabetic retinopathy screening through telemedicine in low- and middle-income countries.Indian journal of ophthalmology · 2021Review
- Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic.Cureus · 2021Review
- Evaluation of multi-level barriers and facilitators in a large diabetic retinopathy screening program in federally qualified health centers: a qualitative study.Implementation science communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewWe discuss opportunities to address key barriers to widespread implementation of teleophthalmology programs for diabetic eye screening in the United States (U.S.). RECENT
findingsTeleophthalmology is an evidence-based form of diabetic eye screening. This technology has been proven to substantially increase diabetic eye screening rates and decrease blindness. However, teleophthalmology implementation remains limited among U.S. health systems. Major barriers include financial concerns as well as limited utilization by providers, clinical staff, and patients. Possible interventions include increasingly affordable camera technology, demonstration of financially sustainable billing models, and engaging key stakeholders. Significant opportunities exist to overcome barriers to scale up and promote widespread implementation of teleophthalmology in the USA. Further development of methods to sustain effective increases in diabetic eye screening rates using this technology is needed. In addition, the demonstration of cost-effectiveness in a variety of billing models should be investigated to facilitate widespread implementation of teleophthalmology in U.S. health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.